Navya Parsa, MD
Rheumatology · Columbus, OHNPI 1104183011
Payments from drug & device makers
Across 592 payments — averaging $14.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$2K
- Novartis$963
- Johnson & Johnson$836
- UCB, Inc.$409
- AstraZeneca$339
- plus $2K from 18 others
What the payments were for
- Food & beverage$8,40099%
- Education$641%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 174 | $2,338 |
| Amgen(2 entities) | 143 | $1,752 |
| Novartis | 69 | $963 |
| Johnson & Johnson | 47 | $836 |
| UCB, Inc. | 25 | $409 |
| AstraZeneca(2 entities) | 16 | $339 |
| Pfizer | 19 | $337 |
| Genentech USA, Inc. | 37 | $329 |
| GSK | 14 | $250 |
| Lilly USA, LLC | 9 | $167 |
| Organon | 6 | $140 |
| Bristol Myers Squibb | 7 | $134 |
| Radius Health, Inc. | 6 | $102 |
| Aurinia Pharma U.S., Inc. | 4 | $87 |
| Octapharma USA, Inc. | 4 | $72 |
| Fresenius Kabi USA, LLC | 3 | $56 |
| Sobi, Inc | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 1 | $28 |
| Antares Pharma, Inc. | 1 | $19 |
| Mylan Institutional Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $18 |
| Sanofi | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Mallinckrodt Hospital Products Inc. | 1 | $12 |
How this compares
$8,465 in reported general payments places this provider in the 70th percentile of 255 rheumatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 27 | $189,302 |
| Xeljanz XrTofacitinib Citrate | 26 | $148,064 |
| Enbrel SureclickEtanercept | 13 | $94,950 |
| Actemra ActpenTocilizumab | 26 | $91,315 |
| Hydroxychloroquine Sulfate | 202 | $11,852 |
| MethotrexateMethotrexate Sodium | 427 | $7,917 |
| Mycophenolate Mofetil | 27 | $3,874 |
| Celecoxib | 48 | $2,889 |
| Gabapentin | 107 | $1,856 |
| Prednisone | 268 | $1,154 |
| Allopurinol | 89 | $1,146 |
| Azathioprine | 47 | $1,127 |
| Colchicine | 17 | $1,047 |
| Duloxetine Hcl | 50 | $940 |
| Alendronate Sodium | 75 | $693 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Columbus
- Alexa MearaColumbus$478K
- Eric GreidingerColumbus$169K
- Ali AjamColumbus$166K
- Kevin SchlesselColumbus$63K
- Zhanna MikulikColumbus$59K
- Jacob SeymourColumbus$27K
- Sheryl MascarenhasColumbus$20K
- Heather LakeColumbus$13K
- Isam DiabMiddleburg Hts$15.3M
- Sanford WolfeDayton$4.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.